Lomustine
AIDS-related Lymphoblastic Lymphoma
AIDS Malignancy ConsortiumSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the AIDS-related Lymphoblastic Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ETOPOSIDE AIDS Malignancy Consortium | Phase 2 | B |
Inno-206 AIDS Malignancy Consortium | Phase 2 | B |
VINCRISTINE SULFATE AIDS Malignancy Consortium | Phase 2 | B |
Hycamtin National Cancer Institute (NCI) | Phase 2 | B |
Procarbazine AIDS Malignancy Consortium | Phase 2 | B |
View all 21 →
Same molecule, other indications
Lomustine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →